Vildagliptin: an anti-diabetes agent ameliorates cognitive deficits and pathology observed in streptozotocin-induced Alzheimer's disease
出版年份 2013 全文链接
标题
Vildagliptin: an anti-diabetes agent ameliorates cognitive deficits and pathology observed in streptozotocin-induced Alzheimer's disease
作者
关键词
-
出版物
JOURNAL OF PHARMACY AND PHARMACOLOGY
Volume 65, Issue 12, Pages 1773-1784
出版商
Wiley
发表日期
2013-10-12
DOI
10.1111/jphp.12148
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Modeling Sporadic Alzheimer's Disease: The Insulin Resistant Brain State Generates Multiple Long-Term Morphobiological Abnormalities Including Hyperphosphorylated Tau Protein and Amyloid-β
- (2017) Melita Salkovic-Petrisic et al. JOURNAL OF ALZHEIMERS DISEASE
- Alzheimer Disease and Diabetes Mellitus: Do They have Anything in Common?
- (2013) Ernest Adeghate et al. Current Alzheimer Research
- 2012 Alzheimer’s disease facts and figures
- (2012) Alzheimers & Dementia
- The glucagon-like peptide 1 analog liraglutide reduces TNF-α-induced oxidative stress and inflammation in endothelial cells
- (2012) Aya Shiraki et al. ATHEROSCLEROSIS
- Comparison of neuroprotective effects of five major lipophilic diterpenoids from Danshen extract against experimentally induced transient cerebral ischemic damage
- (2012) Ok Kyu Park et al. FITOTERAPIA
- Withania somnifera reverses Alzheimer's disease pathology by enhancing low-density lipoprotein receptor-related protein in liver
- (2012) N. Sehgal et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Amelioration of neurodegenerative changes in cellular and rat models of diabetes-related Alzheimer’s disease by exendin-4
- (2011) Song Chen et al. AGE
- Improvement of brain energy metabolism and cholinergic functions contributes to the beneficial effects of silibinin against streptozotocin induced memory impairment
- (2011) Santoshkumar Tota et al. BEHAVIOURAL BRAIN RESEARCH
- (Val8) glucagon-like peptide-1 prevents tau hyperphosphorylation, impairment of spatial learning and ultra-structural cellular damage induced by streptozotocin in rat brains
- (2011) Lin Li et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Amyloid-β: The seeds of darkness
- (2011) Michelle T. Fodero-Tavoletti et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- The Diabetes Drug Liraglutide Prevents Degenerative Processes in a Mouse Model of Alzheimer's Disease
- (2011) P. L. McClean et al. JOURNAL OF NEUROSCIENCE
- Val(8)GLP-1 rescues synaptic plasticity and reduces dense core plaques in APP/PS1 mice
- (2010) Simon Gengler et al. NEUROBIOLOGY OF AGING
- Long-term inhibition of dipeptidyl peptidase-4 in Alzheimer’s prone mice
- (2009) Michele D’Amico et al. EXPERIMENTAL GERONTOLOGY
- Effect of chronic treatment of carvedilol on oxidative stress in an intracerebroventricular streptozotocin induced model of dementia in rats
- (2009) Atish Kumar Prakash et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Receptors for the incretin glucagon-like peptide-1 are expressed on neurons in the central nervous system
- (2009) Alison Hamilton et al. NEUROREPORT
- Consumption of Grape Seed Extract Prevents Amyloid-β Deposition and Attenuates Inflammation in Brain of an Alzheimer’s Disease Mouse
- (2009) Yan-Jiang Wang et al. NEUROTOXICITY RESEARCH
- Chronic treatment with tocotrienol, an isoform of vitamin E, prevents intracerebroventricular streptozotocin-induced cognitive impairment and oxidative–nitrosative stress in rats
- (2009) Vinod Tiwari et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Modulation of celecoxib- and streptozotocin-induced experimental dementia of Alzheimer's disease by pitavastatin and donepezil
- (2008) Bhupesh Sharma et al. JOURNAL OF PSYCHOPHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started